News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
308,202 Results
Type
Article (14920)
Company Profile (305)
Press Release (292977)
Section
Business (92147)
Career Advice (317)
Deals (18336)
Drug Delivery (34)
Drug Development (52856)
Employer Resources (34)
FDA (6582)
Job Trends (6338)
News (166749)
Policy (12162)
Tag
Academia (1010)
Alliances (25289)
Alzheimer's disease (800)
Approvals (6557)
Artificial intelligence (63)
Bankruptcy (154)
Best Places to Work (5558)
Biotechnology (248)
Breast cancer (68)
Cancer (728)
Cardiovascular disease (63)
Career advice (279)
CAR-T (56)
Cell therapy (182)
Clinical research (41932)
Collaboration (248)
Compensation (100)
COVID-19 (1060)
C-suite (71)
Cystic fibrosis (68)
Data (824)
Diabetes (77)
Diagnostics (1766)
Earnings (32985)
Events (53031)
Executive appointments (217)
FDA (6905)
Funding (268)
Gene editing (56)
Gene therapy (149)
GLP-1 (309)
Government (1262)
Healthcare (7884)
Infectious disease (1098)
Inflammatory bowel disease (95)
IPO (9858)
Job creations (1043)
Job search strategy (254)
Layoffs (189)
Legal (2134)
Lung cancer (115)
Manufacturing (82)
Medical device (4113)
Medtech (4114)
Mergers & acquisitions (8613)
Metabolic disorders (234)
Neuroscience (1021)
NextGen Class of 2024 (2734)
Non-profit (1069)
Northern California (1008)
Obesity (129)
Opinion (96)
Parkinson's disease (65)
Patents (57)
People (28620)
Phase I (14563)
Phase II (19406)
Phase III (12571)
Pipeline (337)
Postmarket research (938)
Preclinical (6113)
Radiopharmaceuticals (213)
Rare diseases (173)
Real estate (1887)
Regulatory (9451)
Research institute (1049)
Southern California (925)
Startups (2225)
United States (8512)
Vaccines (177)
Weight loss (78)
Date
Today (65)
Last 7 days (545)
Last 30 days (2511)
Last 365 days (22751)
2024 (20883)
2023 (24926)
2022 (30380)
2021 (31999)
2020 (27627)
2019 (20244)
2018 (14875)
2017 (16284)
2016 (14087)
2015 (17415)
2014 (12560)
2013 (9380)
2012 (9579)
2011 (9513)
2010 (9024)
Location
Africa (177)
Arizona (63)
Asia (19130)
Australia (3113)
California (2301)
Canada (747)
China (173)
Colorado (83)
Connecticut (96)
Europe (39394)
Florida (269)
Georgia (71)
Illinois (147)
Indiana (90)
Kansas (59)
Maryland (338)
Massachusetts (1813)
Michigan (87)
Minnesota (105)
New Jersey (605)
New York (656)
North Carolina (510)
Northern California (1008)
Ohio (86)
Pennsylvania (478)
South America (269)
Southern California (925)
Texas (275)
Washington State (237)
308,202 Results for "century therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
November 5, 2024
·
1 min read
Press Releases
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 6, 2024
·
17 min read
Press Releases
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
November 6, 2024
·
8 min read
Business
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune diseases, today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 9, 2024
·
13 min read
Deals
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Century Therapeutics announced plans to expand clinical development for its lead program, CNTY-101, a CD19-targeting iNK cell therapy, into additional autoimmune disease indications.
April 11, 2024
·
13 min read
Business
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
Century Therapeutics, Inc. today reported financial results and business highlights for the full year ended December 31, 2023.
March 14, 2024
·
14 min read
Press Releases
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
September 27, 2024
·
9 min read
Pharm Country
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Century Therapeutics today announced that members of the management team will participate in a virtual fireside chat and panel at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit.
April 23, 2024
·
1 min read
Drug Development
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
Century Therapeutics, an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, announced two poster presentations at the ASGCT 27th Annual Meeting.
May 10, 2024
·
10 min read
Pharm Country
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
Century Therapeutics today announced a poster presentation highlighting interim results from the ongoing Phase 1 ELiPSE-1 study evaluating CNTY-101 in relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL) at the American Society of Clinical Oncology (ASCO) Annual Meeting being held May 31 – June 4, 2024 in Chicago, Illinois.
June 3, 2024
·
11 min read
1 of 30,821
Next
